Review



camp dependent protein kinase inhibitor peptide  (Millipore)


Bioz Verified Symbol Millipore is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Millipore camp dependent protein kinase inhibitor peptide
    Camp Dependent Protein Kinase Inhibitor Peptide, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/camp+dependent+protein+kinase+inhibitor+peptide/pmc07444578-80-9-16
    Average 90 stars, based on 1 article reviews
    camp dependent protein kinase inhibitor peptide - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Cdc25 genes, encoded products and uses thereof
    Article Snippet: Protein samples from the 0–33% fraction (in a volume of 10 ml of EB) were mixed on ice with 40 ml of kinase buffer containing 0.2 mg/ml histone H1, 25 mM ATP, 2 m Ci[q32P]ATP and 10 mM cAMP dependent protein kinase inhibitor peptide (P3294, Sigma).

    Concentration Assay:

    Article Title: Diabetes induced decreases in PKA signaling in cardiomyocytes: The role of insulin
    Article Snippet: .. The reaction was stopped by the addition of 1mM cAMP Dependent Protein Kinase Inhibitor peptide (PKI-tide; Sigma) in a 50% glycerol solution to a final concentration of 45uM. ..



    Similar Products

    camp dependent protein kinase inhibitor peptide  (Millipore)
    90
    Millipore camp dependent protein kinase inhibitor peptide
    Camp Dependent Protein Kinase Inhibitor Peptide, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/camp+dependent+protein+kinase+inhibitor+peptide/pmc07444578-80-9-16
    Average 90 stars, based on 1 article reviews
    camp dependent protein kinase inhibitor peptide - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp dependent protein kinase peptide inhibitor (pkai)  (Promega)
    90
    Promega camp dependent protein kinase peptide inhibitor (pkai)
    Camp Dependent Protein Kinase Peptide Inhibitor (Pkai), supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/camp+dependent+protein+kinase+peptide+inhibitor/pmc06126336-50-17-25
    Average 90 stars, based on 1 article reviews
    camp dependent protein kinase peptide inhibitor (pkai) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase inhibitor peptide (myristoylated-14-22) amide (pki  (Enzo Biochem)
    90
    Enzo Biochem camp-dependent protein kinase inhibitor peptide (myristoylated-14-22) amide (pki
    Camp Dependent Protein Kinase Inhibitor Peptide (Myristoylated 14 22) Amide (Pki, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/myristoylated+pki++14+22++amide/pmc04658264-19-7-18
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase inhibitor peptide (myristoylated-14-22) amide (pki - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase a (pka) inhibitor peptide (pki)14–22  (Tocris)
    90
    Tocris camp-dependent protein kinase a (pka) inhibitor peptide (pki)14–22
    Camp Dependent Protein Kinase A (Pka) Inhibitor Peptide (Pki)14–22, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/protein+kinase+a++pka++inhibitor+h89/pm26002980-38-1-12
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase a (pka) inhibitor peptide (pki)14–22 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase a (pka) inhibitor peptide (pki) 14 –22  (Tocris)
    90
    Tocris camp-dependent protein kinase a (pka) inhibitor peptide (pki) 14 –22
    PGE 2 mediated activation of <t>PKA</t> results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide <t>PKI</t> 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.
    Camp Dependent Protein Kinase A (Pka) Inhibitor Peptide (Pki) 14 –22, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/protein+kinase+a++pka++inhibitor+h89/pmc04472944-28-1-14
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase a (pka) inhibitor peptide (pki) 14 –22 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase peptide inhibitor pki  (Promega)
    90
    Promega camp-dependent protein kinase peptide inhibitor pki
    PGE 2 mediated activation of <t>PKA</t> results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide <t>PKI</t> 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.
    Camp Dependent Protein Kinase Peptide Inhibitor Pki, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/camp+dependent+protein+kinase+peptide+inhibitor/pmc03869295-50-1-7
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase peptide inhibitor pki - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase peptide inhibitor (pki  (Promega)
    90
    Promega camp-dependent protein kinase peptide inhibitor (pki
    PGE 2 mediated activation of <t>PKA</t> results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide <t>PKI</t> 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.
    Camp Dependent Protein Kinase Peptide Inhibitor (Pki, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/camp+dependent+protein+kinase+peptide+inhibitor/pmc03869295-91-1-7
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase peptide inhibitor (pki - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase inhibitor peptide pki  (Bachem)
    90
    Bachem camp-dependent protein kinase inhibitor peptide pki
    PGE 2 mediated activation of <t>PKA</t> results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide <t>PKI</t> 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.
    Camp Dependent Protein Kinase Inhibitor Peptide Pki, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/camp+dependent+protein+kinase+inhibitor+peptide/us08008452-348-26-33
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase inhibitor peptide pki - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase peptide inhibitor (pki)  (Promega)
    90
    Promega camp-dependent protein kinase peptide inhibitor (pki)
    PGE 2 mediated activation of <t>PKA</t> results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide <t>PKI</t> 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.
    Camp Dependent Protein Kinase Peptide Inhibitor (Pki), supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/camp+dependent+protein+kinase+peptide+inhibitor/pm17596563-68-41-47
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase peptide inhibitor (pki) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    camp-dependent protein kinase (pka) peptide inhibitor  (Promega)
    90
    Promega camp-dependent protein kinase (pka) peptide inhibitor
    PGE 2 mediated activation of <t>PKA</t> results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide <t>PKI</t> 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.
    Camp Dependent Protein Kinase (Pka) Peptide Inhibitor, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/camp+dependent+protein+kinase+inhibitor+peptide/catalytic+subunit+of+camp+dependent+protein+kinase/10__1074_slash_jbc__m603768200-101-1-9
    Average 90 stars, based on 1 article reviews
    camp-dependent protein kinase (pka) peptide inhibitor - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    PGE 2 mediated activation of PKA results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide PKI 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.

    Journal: The Journal of Immunology Author Choice

    Article Title: Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells

    doi: 10.4049/jimmunol.1402961

    Figure Lengend Snippet: PGE 2 mediated activation of PKA results in CCR8 expression. ( A ) Naive T cells were stimulated for 5 d with anti-CD3/CD28 beads in the presence of 0.01–10 μM PGE 2 , isoproterenol or CV1808. The percentage of gated CD3 + T cells expressing CCR8 was determined by flow cytometry and plotted as mean ± SD from two to six independent experiments. ( B ) Naive T cells were incubated with PGE 2 alone or PGE 2 in the presence of 0.01–10 μM of antagonists against EP1 (SC19220), EP1/2 (AH6809), or EP4 (L161,982) prior to stimulation with anti-CD3/CD28 beads. After 5 d, the percentage of cells expressing CCR8 was determined by flow cytometry and plotted as a percentage of cells expressing CCR8 relative to PGE 2 alone. Results are plotted from two independent experiments. ( C ) Naive T cells were stimulated in the presence of 0.01–1 μM PGE 2 or the EP-selective agonists 19R(OH)-PGE 1 (EP1), butaprost (EP2), or CAY10598 (EP4). After 5 d, the percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry, and results are plotted as mean ± SD from four independent experiments. ( D and E ) Naive T cells were pretreated with 0.01–1 μM of the inhibitors Raf1 kinase inhibitor 1 (RKI1), wortmannin, or PKA inhibitor peptide PKI 14–22 (PKI) prior to stimulation in the presence of PGE 2 . Representative dot plots for CCR8 expression by gated CD3 + T cells stimulated in the presence of PGE 2 alone or PGE 2 + 1 μM PKI are shown in (D), whereas bar graphs depicting the percentage of CD3 + T cells expressing CCR8 for inhibitor-treated groups relative to PGE 2 alone are plotted in (E). ( F ) Naive T cells were stimulated for 5 d in the presence of 0.1 mM of site-specific cAMP agonists selective for activation of PKA-I (2-Cl-8-MA-cAMP + 8-Pip-cAMP) and PKA-II (N6-MBC-cAMP + 8-Pip-cAMP) . The percentage of CD3 + T cells expressing CCR8 was determined by flow cytometry after 5 d and plotted as mean ± SD from two independent experiments. * p < 0.05, ** p < 0.01.

    Article Snippet: The cAMP-dependent protein kinase A (PKA) inhibitor peptide (PKI) 14 –22 was obtained from Tocris Bioscience, whereas Raf1 kinase inhibitor 1 and wortmannin were from Enzo Life Sciences.

    Techniques: Activation Assay, Expressing, Flow Cytometry, Incubation